Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.

A federal judge denied a bid by CVS Health, Cigna and UnitedHealth Group to block the Federal Trade Commission's pricing case ...

The appointment marks the latest in a spate of leadership changes at CVS as the company’s insurance segment struggles to ...

CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.

Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.

CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim ...

In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...

DeVaney led CVS Caremark sales and account management as president, Employer & Health Plans. CVS Health. This story was ...

Today, CVS Health® (NYSE: CVS) named Ed DeVaney president of the company's CVS Caremark pharmacy benefit management business. He was named interim president in December 2024. DeVaney will report ...

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...

CVS’s stock soared toward after its quarterly profit beat expectations by the widest margin in more than four years.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...